skip to Main Content
Phone: 301-655-1084 Email: info@glycomantra.com

GlycoMantra received a SBIR Phase 1 grant from the NIDDK (NIH)

GlycoMantra was awarded a SBIR Phase 1 grant to investigate NASH fibrosis.

read more

GlycoMantra received SBIR Phase 1 grant from the NCI (NIH)

July 18, 2018 GlycoMantra received SBIR Phase 1 grant from the NCI (NIH) GlycoMantra was…

read more

GlycoMantra received a CDMRP grant from the DOD.

June 12, 2018 GlycoMantra received a CDMRP grant from the DOD. GlycoMantra was awarded a…

read more

GlycoMantra published a paper in Oncotarget

October 20, 2017 GlycoMantra published a paper in Oncotarget Studies suggest that tunicamycin may work…

read more
Back To Top